Mersana Therapeutics Inc (NASDAQ:MRSN) price on Thursday, June 12, fall -4.55% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.36.
A look at the stock’s price movement, the close in the last trading session was $0.38. Turning to its 52-week performance, $2.83 and $0.26 were the 52-week high and 52-week low respectively. Overall, MRSN moved 1.37% over the past month.
Mersana Therapeutics Inc’s market cap currently stands at around $45.25 million, with investors looking forward to this quarter’s earnings report slated for in July.
The average forecast suggests up to a 164.16% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 22.16M, representing a -45.28% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MRSN is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend MRSN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MRSN’s current price about -0.94% and 2.65% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.73, while 7-day volatility ratio is 5.04% and 7.82% in the 30-day chart. Further, Mersana Therapeutics Inc (MRSN) has a beta value of 0.82, and an average true range (ATR) of 0.04. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -733.33% off current price level while to achieve the yearly target high, price needs to move -733.33%. Nonetheless, investors will most likely welcome a -733.33% jump to $3 which is the analysts’ median price.
If we refocus on Mersana Therapeutics Inc (NASDAQ:MRSN), historical trading data shows that trading volumes averaged 2.87 million over the past 3 months. The company’s latest data on shares outstanding shows there are 124.63 million shares.
The 22.30% of Mersana Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 50.20% of the company’s shares. Current price change has pushed the stock -74.61% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MRSN stock continues to rise going into the next quarter.
